NEW YORK - With Americans still waiting for regulators to greenlight Pfizer’s antiviral COVID-19 pill, the Biden administration moved to secure millions of doses for patients.Pfizer announced Friday that the White House purchased 10 million treatment courses of its investigational COVID-19 oral antiviral candidate Paxlovid.
The pill won’t be available to the public until it becomes authorized by federal regulators.But once it achieves that, it could be a gamechanger in keeping hospital rates down amid future surges.